AMERICAN FORK, Utah--(BUSINESS WIRE)--Henry Schein One, the market leader in dental practice management systems, today announced the launch of AI-driven Image Verify, the latest innovation in a rapid series of product advancements designed to deliver the cleanest claims experience in dentistry. Image Verify, natively embedded in Dentrix and Dentrix Ascend, represents another major step towards the company's bold Clean Claims vision – a future where dental practices submit claims once and never.
Rhumbline Advisers trimmed its holdings in shares of Henry Schein, Inc. (NASDAQ: HSIC) by 3.2% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 273,400 shares of the company's stock after selling 9,004 shares during the period. Rhumbline Advisers owned
Henry Schein (HSIC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
HSIC gears up for Q4 results, with revenues seen rising 4.5% and strength across dental, medical and tech segments shaping expectations.
AMERICAN FORK, Utah--(BUSINESS WIRE)--Henry Schein One today announced a direct data integration between Align Technology's iTero™ intraoral scanners and its core practice management platforms—Dentrix, Dentrix Ascend, and Dentally—creating a seamless connection between digital scanning, diagnosis, and daily operations for practices worldwide. Developed in collaboration with Align Technology, the integration automatically imports iTero scans into patient records, eliminating manual uploads, dupl.
HOUSTON--(BUSINESS WIRE)--The American Dental Association Foundation (ADAF) is officially kicking off Give Kids A Smile® (GKAS) 2026 at UTHealth Houston School of Dentistry, marking 24 years of transforming children's lives through this access-to-oral-health-care initiative. What began as a local grassroots movement in St. Louis, MO, has evolved into a national movement, having served more than 10.2 million underserved children since 2003. GKAS begins nationally in February, which is National C.
MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC), the world's largest provider of healthcare solutions to office-based dental and medical practitioners, announced today that it will release its fourth quarter 2025 financial results before the stock market opens on Tuesday, February 24, 2026, and will provide a live webcast of its earnings conference call on the same day beginning at 8:00 a.m. Eastern time. Speakers on the call will include Stanley M. Bergman, Chairman of the B.
Dilation Capital Management LP bought a new stake in Henry Schein, Inc. (NASDAQ: HSIC) in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm bought 76,920 shares of the company's stock, valued at approximately $5,105,000. Henry Schein accounts for 2.5% of
IRVINE, Calif.--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC) has entered into a new exclusive distribution agreement with CytoChip Inc. for its flagship product, the CitoCBC® system, a U.S. Food and Drug Administration (FDA) 510(k)-cleared device. Available now to Henry Schein customers in the United States, the CitoCBC system is the first cartridge-based Complete Blood Count (CBC) system to receive a CLIA Waiver, helping expand access to accurate, lab-quality testing at the point of care.
Henry Schein, Inc. (HSIC) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
